Drug discovery

It’s time for pharma to join the crowdsourcing revolution.

There is a shocking lack of attention given to racemization in drug discovery, despite it having huge implications on the efficacy – and safety – of drugs. We hope the tool we have developed will be the first step towards change.

A tool to predict racemization could help prevent drug discovery dead ends

New cancer treatments may be lying right under our noses – if we are willing to take a commercial risk.

Should we target minor rather than major infections with new therapeutics to best fight antibiotic resistance?

An analgesic is helping researchers explore new drug targets for sight-threatening diseases

The gates for gene and cell therapies are open, and RNAi technology could be a serious contender

Renã Robinson, Assistant Professor, University of Pittsburgh, Pennsylvania, USA

Could donated human skin provide a viable alternative to animal testing?

Eleftherios P. Diamandis, Hold ’em for Life Chair in Prostate Cancer Biomarkers, University of Toronto.